Skip to main content

Table 2 Comparison of hedgehog signal expression associated with clinicopathological parameters

From: Usability of serum hedgehog signalling proteins as biomarkers in canine mammary carcinomas

 

Number of patients (n)

SHH (ng/mL)

P value

GLI-1 (ng/mL)

P value

Sex

 Female

20

4.17 ± 2.42

 

29.31 ± 10.11

 

 Spayed female

23

4.84 ± 1.71

.165

27.22 ± 13.40

.903

Breed size

  ≤ 10 kg

36

4.56 ± 2.10

 

27.50 ± 12.47

 

  > 10 kg

7

4.39 ± 2.08

.936

31.78 ± 8.06

.468

Tumour size

  ≤ 3 cm

24

4.03 ± 2.01

 

27.28 ± 9.48

 

 3–5 cm

7

4.88 ± 2.83

 

27.43 ± 16.56

 

  > 5 cm

12

5.32 ± 1.54

.154

30.47 ± 13.95

.534

Benign MGT

 Simple

9

4.69 ± 1.72

 

26.21 ± 12.23

 

 Complex

11

3.21 ± 1.47

 

22.79 ± 12.76

 

 Mixed

6

4.25 ± 1.91

.150

24.02 ± 10.76

.925

Malignant MGT

 Simple

10

4.32 ± 1.66

 

31.29 ± 7.02

 

 Complex

1

 ± 7.67 ± 

 

 ± 32.92 ± 

 

 Mixed

3

5.41 ± 2.23

.175

29.51 ± 5.36

.925

Histologic grade

 Grade 1

12

4.72 ± 2.01

 

30.00 ± 5.58

 

 Grade 2

3

5.85 ± 0.28

.448

37.94 ± 65.54

.048*

Metastasis

 Metastatic

6

7.26 ± 1.79

 

42.96 ± 9.81

 

 Non-metastatic

11

4.39 ± 1.91

.01*

29.44 ± 5.16

.007*

  1. Continuous variables are presented as mean and SD
  2. *P value < .05 indicates that the clinicopathological variable is considered to be statistically significant